Health
Study reveals mechanisms behind sensitivity of multiple myeloma cells to EZH2 inhibition – News-Medical.net
Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma….
Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma. The reduction is caused by changes in the cancer cells’ metabolism. These changes can be used as markers to discriminate whether a patient would respond to treatment by EZH2 inhibition. The study has been published in the journal Cell Death & Disease.
Multiple myeloma is a type of blood cancer where immune cells grow in an uncontrolled…
-
Noosa News24 hours agoFranz Ferdinand: Australian Tour 2025
-
General18 hours agoDavid Littleproud’s own goal • Inside Story
-
Noosa News17 hours agoQueensland GP accused of rape, sexual assault and torture pleads for bail despite ‘disturbing’ allegations
-
Business24 hours agoHow these 5 ASX 200 stocks are smashing the benchmark this week